Royal Bank of Canada’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95K | Sell |
86,365
-10,294
| -11% | -$11.3K | ﹤0.01% | 5290 |
|
|
2025
Q1 | $95K | Buy |
96,659
+69,006
| +250% | +$67.8K | ﹤0.01% | 4905 |
|
|
2024
Q4 | $44K | Sell |
27,653
-7,673
| -22% | -$12.2K | ﹤0.01% | 5266 |
|
|
2024
Q3 | $130K | Buy |
35,326
+5,133
| +17% | +$18.9K | ﹤0.01% | 4720 |
|
|
2024
Q2 | $100K | Buy |
30,193
+4,593
| +18% | +$15.2K | ﹤0.01% | 4882 |
|
|
2024
Q1 | $109K | Buy |
25,600
+24,647
| +2,586% | +$105K | ﹤0.01% | 4711 |
|
|
2023
Q4 | $2K | Sell |
953
-2,320
| -71% | -$4.87K | ﹤0.01% | 6288 |
|
|
2023
Q3 | $6K | Sell |
3,273
-34,402
| -91% | -$63.1K | ﹤0.01% | 6082 |
|
|
2023
Q2 | $96K | Sell |
37,675
-34,870
| -48% | -$88.9K | ﹤0.01% | 4933 |
|
|
2023
Q1 | $291K | Buy |
+72,545
| New | +$291K | ﹤0.01% | 3962 |
|
|
2022
Q4 | – | Sell |
-192
| Closed | – | – | 7060 |
|
|
2022
Q3 | $0 | Buy |
+192
| New | – | ﹤0.01% | 7205 |
|
|
2022
Q2 | – | Sell |
-653
| Closed | -$3K | – | 7084 |
|
|
2022
Q1 | $3K | Sell |
653
-1,483
| -69% | -$6.81K | ﹤0.01% | 6906 |
|
|
2021
Q4 | $23K | Buy |
+2,136
| New | +$23K | ﹤0.01% | 6209 |
|